Approval · Notice of Compliance 12202 · 2011
APO-FINASTERIDE: Notice of Compliance 12202
Issued March 21, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12202
- Date
- March 21, 2011
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Type II 5 alpha-reductase inhibitor
- Canadian reference product
- PROSCAR (Merck Frosst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-FINASTERIDE | 02365383 | Dormant |
Medicinal ingredients
- FINASTERIDE 5 MG per TAB